Haemonetics Dividends
| HAE Stock | USD 58.67 0.91 1.58% |
As of February 17, 2026, Dividends Paid is expected to decline to about 4.8 M. In addition to that, Dividend Yield is expected to decline to 0.01. Haemonetics' past performance could be the main factor of why investors trade Haemonetics stock today. Investors should clearly understand every aspect of the Haemonetics dividend schedule, including its future sustainability, and how it might impact an overall investment strategy. This tool is helpful to digest Haemonetics' dividend schedule and payout information. Haemonetics dividends can also provide a clue to the current valuation of Haemonetics.
| Last Reported | Projected for Next Year | ||
| Dividends Paid | 8.1 M | 4.8 M | |
| Dividend Yield | 0.01 | 0.01 | |
| Dividend Payout Ratio | 0.22 | 0.19 | |
| Dividend Paid And Capex Coverage Ratio | 2.74 | 1.78 |
Haemonetics | Build AI portfolio with Haemonetics Stock |
Investing in stocks that pay dividends is one of many strategies that are good for long-term investments. Ex-dividend dates are significant because investors in Haemonetics must own a stock before its ex-dividend date to receive its next dividend.
Haemonetics Dividends Paid Over Time
Today, most investors in Haemonetics Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Haemonetics' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's dividends paid growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Haemonetics dividends paid as a starting point in their analysis.
The total amount of dividends that a company has paid out to its shareholders over a specific period. Dividends Paid |
| Timeline |
Haemonetics Historical Dividend Yield Growth
A solid dividend growth pattern of Haemonetics could indicate future dividend growth is likely, which can signal long-term profitability for Haemonetics. When investors calculate the dividend yield growth rate, they can use any interval of time they wish. They may also calculate the dividend yield growth rate using the least-squares method or simply take an annualized figure over a given time period. Dividend Yield is Haemonetics dividend as a percentage of Haemonetics stock price. Haemonetics dividend yield is a measure of Haemonetics stock productivity, which can be interpreted as interest rate earned on an Haemonetics investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share. Dividend Yield |
| Timeline |
Will Health Care Equipment & Supplies sector continue expanding? Could Haemonetics diversify its offerings? Factors like these will boost the valuation of Haemonetics. Market participants price Haemonetics higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Haemonetics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 0.284 | Earnings Share 3.63 | Revenue Per Share | Quarterly Revenue Growth (0.03) | Return On Assets |
The market value of Haemonetics is measured differently than its book value, which is the value of Haemonetics that is recorded on the company's balance sheet. Investors also form their own opinion of Haemonetics' value that differs from its market value or its book value, called intrinsic value, which is Haemonetics' true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Haemonetics' market value can be influenced by many factors that don't directly affect Haemonetics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Haemonetics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Haemonetics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Haemonetics' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.